Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
Go back to Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development| AGENUS (NASDAQ: AGEN) | Delayed: 3.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.00 | 52 Week High | $7.49 | |||
| Open | $3.00 | 52 Week Low | $2.61 | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $3.00 | EPS | $-1.10 | |||
| Volume | 38 | |||||
| (NASDAQ: INKT) | Delayed: 12.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.14 | 52 Week High | $ | |||
| Open | $12.14 | 52 Week Low | $ | |||
| Day High | $12.14 | P/E | N/A | |||
| Day Low | $12.14 | EPS | $ | |||
| Volume | 263 | |||||

